Showing results (721-730 of 1,155) with videos related to

Sort By:
Pageof 116
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Rheumatology Advances in Practice|February 1, 2021
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature reviewHamish Farquhar, Ana B Vargas-Santos, Huai Leng Pisaniello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expressionH S Pandha, L A Martin, A Rigg, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Molecular and Cellular Biology|July 16, 2004
Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditisMasashi Morita, Gordon Stamp, Peter Robins, et al.
Peptides|June 5, 2004
TFF1 is membrane-associated in breast carcinoma cell line MCF-7Lai-San Siu, Hanna Romanska, Paul D Abel, et al.
Peptides|June 5, 2004
TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell linesLai-San Siu, Hanna Romanska, Paul D Abel, et al.
Rheumatology International|September 28, 2015
Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and goutTahzeeb Fatima, Sara Altaf, Amanda Phipps-Green, et al.
Pageof 116